1. The tale of refractory recurrent pericarditis

   • George Lazaros
   • Alexios Antonopoulos
   • Konstantinos Tsioufis

   IM - COMMENTARY 18 March 2021 Pages: 537 - 539

   

2. Procalcitonin in daily clinical practice: an evergreen tool also during a pandemic

   • Alessandro Russo
   • Mario Venditti
   • Gabriella d’Ettorre

   IM - COMMENTARY 12 February 2021 Pages: 541 - 543

   

3. Smoking cessation in COPD: confronting the challenge

   • Donald P. Tashkin

   IM - COMMENTARY Open access 25 March 2021 Pages: 545 - 547

4. Adverse drug reactions in the era of COVID-19

   • Angela P. Cornelius

   IM - COMMENTARY 13 March 2021 Pages: 549 - 550

5. Recurrent pericarditis: an update on diagnosis and management

   • Alessandro Andreis
   • Massimo Imazio
   • Antonio Brucato

   IM - REVIEW 28 February 2021 Pages: 551 - 558

   

6. Unmet needs in the management of exacerbations of chronic obstructive pulmonary disease

   • Kiki Waeijen-Smit
   • Sarah Houben-Wilke
   • Frits M. E. Franssen

   IM - REVIEW Open access 22 February 2021 Pages: 559 - 569

   

7. Follow-up management of patients receiving direct oral anticoagulants

   • Chiara Fantoni
   • Lorenza Bertù
   • Walter Ageno

   IM - ORIGINAL 13 July 2020 Pages: 571 - 580

8. Healthcare and economic burden of ANCA-associated vasculitis in Italy: an integrated analysis from clinical and administrative databases

   • Luca Quartuccio
   • Elena Treppo
   • Salvatore De Vita

   IM - ORIGINAL Open access 14 July 2020 Pages: 581 - 589

   

9. Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry

   • Giulia Renda
   • Ladislav Pecen
   • Raffaele De Caterina

   IM - ORIGINAL Open access 21 September 2020 Pages: 591 - 599

   

10. Epidemiology and factors associated with mortality of thyroid storm in Taiwan: a nationwide population-based study

    • Edy Kornelius
    • Kuang-Leei Chang
    • Sai-Wai Ho

    IM - ORIGINAL 16 July 2020 Pages: 601 - 607

    

11. When should a rare inherited connective tissue disorder be suspected in bicuspid aortic valve by primary-care internists and cardiologists? Proposal of a score

    • Guglielmina Pepe
    • Betti Giusti
    • Stefano Nistri

    IM - ORIGINAL Open access 19 September 2020 Pages: 609 - 615

    

12. Serum sodium variability and acute kidney injury: a retrospective observational cohort study on a hospitalized population

    • Gianmarco Lombardi
    • Pietro Manuel Ferraro
    • Giovanni Gambaro

    IM - ORIGINAL Open access 09 August 2020 Pages: 617 - 624

13. Plasma irisin levels are associated with hemodynamic and clinical outcome in idiopathic pulmonary arterial hypertension patients

    • Na Sun
    • Yiqiang Chen
    • Bingxiang Wu

    IM - ORIGINAL 14 August 2020 Pages: 625 - 632

    

14. Association of overlap syndrome with incident atrial fibrillation

    • Morohunfolu Akinnusi
    • Abdul Rahman El-Masri
    • Ali Albert El-Solh

    IM - ORIGINAL 17 August 2020 Pages: 633 - 642

    

15. Modes of death in heart failure according to age, sex and left ventricular ejection fraction

    • Prado Salamanca-Bautista
    • Jesús Álvarez-García
    • the REDINSCOR, RICA Investigators groups

    IM - ORIGINAL 19 August 2020 Pages: 643 - 652

    

16. Poor right ventricular function is associated with impaired exercise capacity and ventilatory efficiency in transthyretin cardiac amyloid patients

    • Simone Bartolini
    • Samuele Baldasseroni
    • Francesco Cappelli

    IM - ORIGINAL 12 September 2020 Pages: 653 - 660

17. New indices of arterial stiffness correlate with disease severity and mid-term prognosis in acute decompensated heart failure

    • Junteng Zhou
    • Yushu Wang
    • Qing Zhang

    IM - ORIGINAL 04 September 2020 Pages: 661 - 668

    

18. Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience

    • Carlo Tascini
    • Giovanni Sermann
    • Amato De Monte

    IM - ORIGINAL 01 November 2020 Pages: 669 - 675

    

19. Clinical outcomes and costs associated with procalcitonin utilization in hospitalized patients with pneumonia, heart failure, viral respiratory infection, or chronic obstructive pulmonary disease

    • Stacy Aric Johnson
    • Austin Bernard Rupp
    • Santosh Reddy

    IM - ORIGINAL 16 January 2021 Pages: 677 - 686

    

20. Health outcomes in COPD smokers using heated tobacco products: a 3-year follow-up

    • Riccardo Polosa
    • Jaymin B. Morjaria
    • Pasquale Caponnetto

    IM - ORIGINAL Open access 23 March 2021 Pages: 687 - 696

    

21. Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions

    • Giada Crescioli
    • Valentina Brilli
    • Niccolò Lombardi

    IM - ORIGINAL Open access 23 December 2020 Pages: 697 - 710

22. Prevalence and risk factors of long-term proton pump inhibitors-associated hypomagnesemia: a cross-sectional study in hospitalized patients

    • Delfina Ana Recart
    • Augusto Ferraris
    • Maria Lourdes Posadas-Martinez

    IM - ORIGINAL 01 October 2020 Pages: 711 - 717

    

23. The association of diabetes and hyperglycemia with sepsis outcomes: a population-based cohort analysis

    • Yarden Zohar
    • Shani Zilberman Itskovich
    • Ronit Koren

    IM - ORIGINAL 22 September 2020 Pages: 719 - 728

    

24. Not all that trembles…: a rare case of extrapyramidal impairment

    • Matteo Landolfo
    • Alessio Bragagni
    • Claudio Borghi

    Case Record 18 December 2019 Pages: 729 - 733

    

25. Request of hospital care dropped for TIA but remained stable for stroke during COVID-19 pandemic at a large Italian university hospital

    • Maurizio Balestrino
    • Alberto Coccia
    • Angelo Schenone

    EM - ORIGINAL Open access 15 October 2020 Pages: 735 - 739

    

26. Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study)

    • Silvia Pagani
    • Niccolò Lombardi
    • The MEREAFaPS Study group

    EM - ORIGINAL 04 January 2021 Pages: 741 - 748

27. The role of lung ultrasound as a frontline diagnostic tool in the era of COVID-19 outbreak

    • Cristina Sorlini
    • Marco Femia
    • the Fenice Network (Italian Group for Clinical Research in Emergency Medicine)

    EM - ORIGINAL 22 October 2020 Pages: 749 - 756

    

28. Prognostic stratification in septic patients with overt and cryptic shock by speckle tracking echocardiography

    • Francesca Innocenti
    • Vittorio Palmieri
    • Riccardo Pini

    EM - ORIGINAL 01 November 2020 Pages: 757 - 764

    

29. Gender differences and survival after an out-of-hospital cardiac arrest: a systematic review and meta-analysis

    • Dejing Feng
    • Chuang Li
    • Lefeng Wang

    CE-Systematic reviews and meta-analysis 10 November 2020 Pages: 765 - 775

    

30. Intracranial bruits in meningitis

    • Kenta Sugiura
    • Takateru Ihara

    CE - Physical Examination 03 January 2021 Pages: 777 - 778

    

31. Emphysematous cystitis: delay in diagnosis and treatment complications

    • David da Silva Dias
    • Catarina Jorge
    • Maria Pilar Perez

    CE - MEDICAL ILLUSTRATION 12 August 2020 Pages: 779 - 780

    

32. Milky fluid from the lungs: pulmonary alveolar proteinosis

    • Divya P. Nimmatoori
    • Saurabh Bansal
    • Vijay Mohan Sudigali

    CE - MEDICAL ILLUSTRATION 31 August 2020 Pages: 781 - 782

    

33. Right ventricular lead perforation revealed by diaphragmatic stimulation

    • Damien Nguyen
    • Thomas Nguyen
    • Eva De Keyzer

    CE - MEDICAL ILLUSTRATION 16 September 2020 Pages: 783 - 784

    

34. Can oral formulation increase the risk of lormetazepam abuse?

    • Enrico Costa
    • Enrico Sterzi
    • Fabio Lugoboni

    CE-Research Letter to the Editor 23 October 2020 Pages: 785 - 788

    

35. Superinfection with difficult-to-treat bacteria in COVID-19 patients: a call for compliance with diagnostic and antimicrobial stewardship

    • Ombretta Para
    • Lorenzo Caruso
    • Michele Spinicci

    CE-Research Letter to the Editor 22 November 2020 Pages: 789 - 791

36. The need for a correct oxygen-ozone autohemotherapy (O₃-AHT) in patients with mild to moderate COVID-19 pneumonia

    • Salvatore Chirumbolo
    • Sergio Pandolfi
    • Marianno Franzini

    CE - LETTER TO THE EDITOR 05 January 2021 Pages: 793 - 794

37. Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience: reply

    • Amato De Monte
    • Giovanni Sermann
    • Carlo Tascini

    CE - Letter to the Editor 03 February 2021 Pages: 795 - 796

38. Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment

    • Alfredo Jose Pardo-Cabello
    • Victoria Manzano-Gamero
    • Pilar Giner-Escobar

    CE - LETTER TO THE EDITOR 31 January 2021 Pages: 797 - 798

39. Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions-reply

    • Giada Crescioli
    • Cecilia Lanzi
    • Niccolò Lombardi

    CE-LETTER TO THE EDITOR 26 February 2021 Pages: 799 - 800

40. Are we on brink of a second COVID-19 wave in Italy? Let’s look at Google Trends

    • Jacopo Ciaffi
    • Riccardo Meliconi
    • Francesco Ursini

    CE - LETTER TO THE EDITOR 17 September 2020 Pages: 801 - 802

    

41. Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine

    • Giuseppe Carli
    • Ilaria Nichele
    • Alberto Tosetto

    CE - LETTER TO THE EDITOR 09 March 2021 Pages: 803 - 804

42. Correction to: Teen suicide: an underreported and emerging plague

    • Emiliano Gamberini
    • Etrusca Brogi
    • Costanza Martino

    Correction 19 December 2020 Pages: 805 - 805

43. Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy

    • Stefano Ghio
    • Enrico Baldi
    • San Matteo COVID Cardiac Injury Task Force

    Correction 21 January 2021 Pages: 807 - 807